Are you interested in improving the detection and management of atrial fibrillation (AF)?
Eastern AHSN is offering you a free mobile ECG device to help improve detection.
As part of a national drive to reduce strokes caused by AF, NHS England is supporting the use of innovative mobile ECG devices, distributed through the AHSN network. Eastern AHSN is now inviting expressions of interest (EOI) from all Clinical Commissioning Groups, local networks and care providers across the east of England, to share their vision of how these devices can be deployed to improve AF detection and anti-coagulation treatment.
The device on offer through this scheme in the region is the Kardia Mobile device, produced by AliveCor. Kardia Mobile produces a diagnostic quality ECG on a smartphone or tablet in just 30 seconds. It’s quick and easy to use with no gels, wires or cables and it detects AF effectively. The recorded ECGs can be reviewed, emailed to an NHS email account and printed.
We welcome EOIs from Clinical Commissioning Groups, local networks and care providers in both primary and secondary care settings. Up to 70 devices will be allocated per Sustainable Transformation Plan (STP) region.
Some suggested clinical settings include:
- GP or pharmacy clinics (e.g. flu vaccination)
- Long term conditions clinics e.g. diabetes, heart failure, hypertension, COPD, frailty, falls.
- Community pharmacy
- Community intermediate care services and district nursing
- Diabetic eye screening clinics
Submit your expression of interest form by 5.00 pm on 21 February. Please see the guidance notes for more information on this device including the National Institute for Health and Care Excellence (NICE) Medtech innovation briefing.
Email email@example.com for more information.
Atrial Fibrillation devices timetable:
Expressions of interest deadline – 21 February
Applicant feedback provided – 9 March